Navigation Links
WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
Date:1/3/2008

business, financial condition, results of operations and prospects, see "Risk Factors" beginning on page 11 of our prospectus filed with the Securities and Exchange Commission on August 9, 2007, and available on the Securities and Exchange Commission's website at http://www.sec.gov. Any projections in this release are based on limited information currently available to us, which is subject to change. Although such projections and the factors influencing them will likely change, WuXi PharmaTech undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release. Such information speaks only as of the date of this release.

For more information, please contact:

Investor Contact:

Dr. Hai Mi

Vice President, Corporate Communications

WuXi PharmaTech (Cayman) Inc.

Tel: +86-21-5046-3726

Email: ir@pharmatechs.com

Investor Relations (US):

Mahmoud Siddig

Director

Taylor Rafferty

Tel: +1-212-889-4350

Email: Pharmatechs@taylor-rafferty.com

Investor Relations (HK):

Ruby Yim

Managing Director

Taylor Rafferty

Tel: +852-3196-3712

Email: Pharmatechs@taylor-rafferty.com

Media Contact:

John Dooley

Taylor Rafferty

Tel: +1-212-889-4350

Email: Pharmatechs@taylor-rafferty.com


'/>"/>
SOURCE WuXi PharmaTech
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
2. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
3. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
4. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
5. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
6. WuXi PharmaTech Announces Second Quarter 2007 Results
7. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
8. Inverness Medical Innovations Acquires ParadigmHealth
9. LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
10. Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
11. Raptor Pharmaceuticals Acquires Orphan Clinical Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... 5 GenVec, Inc. (Nasdaq:... the third quarter ended September 30, 2009. GenVe...hare) for the three months ended September 30, 200...r share) in the comparable quarter of 2008. For th...et loss was $14.1 million ($0.15 per share), compa...
(Date:11/5/2009)... Nov. 5 ThermoGenesis Co...tive products for processing and storing adult ste...ter of fiscal 2010. ,, For the quarter ended Se... $5.2 million, a 15 percent increase over revenues...The Company said the key contributors to the growt...
(Date:11/5/2009)... 5 Cepheid (Nasdaq: CPH...eaking at the following investor conferences, and ... Credit Suisse Healthcare Conferenc...ber, 2009 at 10 a.m. Mountain Time, ...nd, Tuesday, 1 December, 2009 at 1...
(Date:11/5/2009)...PRNewswire/ -- SpineSmith Partners has signed an i... a unique scaffold that mimics the structure of na...veral commercial products by SpineSmith,s Research...the GenOsteo scaffold represents a significant adv...deal environment for the delivery of adult stem ce...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...ology To Potentially Improve ...7 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) toda...arch and License Agreement with Genentech, Inc. ex...ional targets for potential improvement,of product...nger,DNA-binding protein nuclease (ZFN) technology...
...Group,(Debiopharm), a global independent biopharma...s medical conditions and particularly oncology, to...cology chair at the Ecole,Polytechnique Federale d...,in Oncogenesis. Funded through a CHF 2.5 million ...ge the wide scope of ideas and inventions,discover...
...generate antibodies against novel resea...rmany and ST. LOUIS, Feb. 27 ,Sigma-Aldrich(TM) (N...xchange: MOR; Prime Standard Segment, TecDAX) toda...roduce and distribute unique,recombinant research ...D(R),technology. MorphoSys,s AbD Serotec unit will...
Other Biology Technology:Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 2Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 3Debiopharm and EPFL Establish an Oncology Chair 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 3
(Date:11/6/2009)...FAIRFAX, Va.Registration is now open for the Socie...erventional Oncology (IO) Therapies" Webinar, whic...and transcatheter treatment of liver tumors, kidne... national organization of physicians, scientists a...ing public health through pioneering advances in i...
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, ...(LEID) will be installing its locker system and pa...BACS) at the U.S. Department of Health and Human S... in Bethesda, MD. The locker system will support ...for protecting our nation,s medical research agenc...
(Date:11/5/2009)...New Haven, Conn.Researchers at Yale University hav...ng the body,s immune response to HIV and HIV-infec...eir findings, published online in the Journal of ...l therapeutic approaches for these diseases. , ...e targeting HIV" (ARM-H) and "antibody-recruiting ...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 1Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 2Mirixa Corporation Announces Key Pharmacy Network Hire 5339 1Mirixa Corporation Announces Key Pharmacy Network Hire 5339 2Newly Updated Pharmacy State Law Compendium Available 5335 1Newly Updated Pharmacy State Law Compendium Available 5335 2
... NYU Langone Medical Center scientists and their ... La Jolla, Calif., have discovered an unexpected c...l meningitis, an infection of the central nervous ...nal Nature. The finding may lead to a new way of t... to viral diseases. , The NYU researchers, Michae...
...adly form of malaria for humans, Plasmodium falci...nzees, this group has been fairly isolated on the ...analysis from the Sackler Institute for Comparativ...ry reveals that malarial parasites found in tree-d...ip with P. falciparum and Plasmodium reichenowi...
...tains, from the Apennines to the Alps, have fascin... Walter Alvarez for more than 35 years, resulting ... that traces Italy,s billion-year geologic history...ndbreaking - and often overlooked - discoveries. ,...n & Company, Inc. Alvarez, a UC Berkeley professor...
Other Biology News:Peering inside the skull of a mouse to solve meningitis mystery 2Peering inside the skull of a mouse to solve meningitis mystery 3African thicket rat malaria linked to virulent human form 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 3Italy's geologic history becomes a personal tale in Walter Alvarez's new book 4
... identified as the cellular homolog of the avian s...been shown to be almost identical to c-Jun in thei...zation and DNA binding, whereas their N-terminal d...vation, diverge. Antigen: The antibody was pro...
Mouse Anti-Yersinia pestis Capsular F1 Antigen Monoclonal Antibody, Unconjugated, Clone YBF19 from QED Bioscience Inc.
Rabbit Anti-JMJD2D Polyclonal Antibody, Unconjugated from Abcam
Perm/Wash Buffer from BD Biosciences Pharmingen
Biology Products: